Laboratory Testing for Hereditary Angioedema
To rule out hereditary angioedema (HAE), the recommended laboratory tests include C4 level, C1 inhibitor (C1INH) antigen level, and C1INH functional activity. 1, 2
Initial Screening
- C4 level: The most cost-effective first screening test
- At least 95% of patients with C1INH deficiency have reduced C4 levels between attacks
- Nearly 100% have low C4 during attacks
- A normal C4 level during an attack strongly suggests an alternative diagnosis 1
Follow-up Testing
If C4 is low OR clinical suspicion remains high despite normal C4:
- C1INH antigen level: Measures the amount of C1INH protein
- C1INH functional activity: Measures how well C1INH works
Interpretation of Results
Type I HAE (85% of cases):
Type II HAE (15% of cases):
Acquired C1INH deficiency:
HAE with normal C1INH (formerly Type III):
Important Considerations
- Positive screening tests should be repeated once to exclude sample degradation or laboratory error 1
- It may be more practical to order C4, C1INH antigen, and C1INH function simultaneously 1, 2
- Ensure blood samples are sent to the laboratory promptly to avoid degradation and artificially low C4 levels 1
- Testing can be performed during or between attacks, but C4 is more reliably low during attacks 1, 2
- A normal C4 level does not completely exclude HAE, especially if measured between attacks 2
Common Pitfalls to Avoid
- Failing to test C1INH function when C1INH antigen is normal 1
- Not considering acquired C1INH deficiency in older patients with new-onset angioedema 2
- Overlooking HAE with normal C1INH in women with recurrent angioedema and normal complement studies 2, 4
- Confusing HAE with ACE inhibitor-induced angioedema (symptoms may persist for up to 6 weeks after discontinuation) 2
By following this systematic approach to laboratory testing, clinicians can effectively rule out or diagnose hereditary angioedema and its variants.